Sign in
4

Changes in Ownership

Vivos Therapeutics, Inc. Filed Acc 0001493152-21-012902

Chief Financial Officer bought 1,000 shares at $5.29 ($5,290)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Amman Bradford K. Chief Financial Officer 2021-05-25 Purchase +1,000 $5.29 $5,290 2,000 D
Open-market purchases · 1,000 sh · avg $5.29 · $5,290
Loading xslF345X03/ownership.xml…